1 Min Read
Aug 10 (Reuters) - Dova Pharmaceuticals Inc
* Dova Pharmaceuticals reports second quarter 2017 operating and financial results
* Qtrly net loss per share, basic and diluted $0.32 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.